Quest Diagnostics Director Timothy Main Buys 21 Shares

What Happened
Timothy L. Main, a director of Quest Diagnostics (DGX), acquired 21 shares on July 22, 2026 at $206.81 per share for a total of about $4,343. This was a purchase (an acquisition) rather than a sale.

Key Details

• Transaction date and price: 2026-07-22 — 21 shares @ $206.81 each (total ≈ $4,343).
• Filing date: Form 4 filed July 27, 2026 (Period of Report: 7/22/2026). The transaction is marked "L" (eligible for deferred reporting).
• Shares owned after the transaction: not stated in the provided filing summary.
• Footnote: The shares were acquired via a dividend reinvestment plan administered by the reporting person’s broker and were eligible for deferred reporting on Form 5 under Rule 16a-6; the insider chose to report the transaction early on Form 4.

Context
Dividend reinvestment plan (DRIP) purchases are routine: dividends are used to buy additional shares and do not necessarily signal a new, active buy decision by the insider. The "L" designation reflects eligibility for deferred reporting rather than a regulatory violation; reporting was submitted promptly on Form 4.